![Dupilumab Improves Atopic Dermatitis and Post-Inflammatory Hyperpigmentation in Patient With Skin of Color | ODAC Dermatology, Aesthetic and Surgical Conference Dupilumab Improves Atopic Dermatitis and Post-Inflammatory Hyperpigmentation in Patient With Skin of Color | ODAC Dermatology, Aesthetic and Surgical Conference](https://orlandoderm.org/wp-content/uploads/2021/04/ODAC_JDDCaseReport_April.png)
Dupilumab Improves Atopic Dermatitis and Post-Inflammatory Hyperpigmentation in Patient With Skin of Color | ODAC Dermatology, Aesthetic and Surgical Conference
![Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/08dc93c5-beb3-4922-b28a-80e404abbd17/gr1.gif)
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
![Lilly's atopic dermatitis med scores another late-stage win in attempt to outdo Dupixent | Fierce Biotech Lilly's atopic dermatitis med scores another late-stage win in attempt to outdo Dupixent | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1640087861/skincream.jpg/skincream.jpg?VersionId=XNxqncWQUywPJHf3ROChcdJz2x4EjG_P)
Lilly's atopic dermatitis med scores another late-stage win in attempt to outdo Dupixent | Fierce Biotech
![Has Dupixent delivered on its promise? The eczema community offers honest feedback | National Eczema Association Has Dupixent delivered on its promise? The eczema community offers honest feedback | National Eczema Association](https://nationaleczema.org/wp-content/uploads/2020/07/Carol-Greenspun-2.png)